← Browse by Condition
Medical Condition
adenocarcinoma gej
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06059495 Phase 2
Recruiting
Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study
Enrollment
59 pts
Location
France
Sponsor
GERCOR - Multidisciplinary Onc...
NCT04984733 Phase 2
Recruiting
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
Enrollment
18 pts
Location
United Kingdom
Sponsor
University of Southampton